Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

Mount Sinai Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Mount Sinai Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Mount Sinai Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Mount Sinai Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Mount Sinai Hospital, a subsidiary of Mount Sinai Health System is a healthcare service provider that offers patient care, education and research, inpatient and support services. The hospital provides services in the areas of palliative care, pathology and laboratory medicine, plastic and reconstructive surgery, urgent care, vascular and endovascular services, among others. It offers adolescent health, ambulatory care, environmental health, emergency medicine, international services, pain management and women's health, among others. Mount Sinai Hospital's support services include patient counseling, social services, advocacy and information services. The hospital's paediatric specialties include cancer, diabetes and endocrinology, gastroenterology and gi surgery, nephrology, neurology and neurosurgery, pulmonology and urology. It also provides inpatient services such as financial assistance, private duty nursing, child life program, and services for international and non-english speaking patients, among others. The hospital also conducts research and offers educational services through its schools. Mount Sinai Hospital is headquartered in New York, the US.

Mount Sinai Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mount Sinai Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mount Sinai Hospital, Medical Devices Deals, 2012 to YTD 2018 9

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Kamada Enters into Agreement with Mount Sinai Acute GvHD International Consortium 11

DBV Technologies Enters Into Research Agreement With Icahn School of Medicine at Mount Sinai For Viaskin 13

National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 15

Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 16

DBV Technologies Enters Into Research Agreement With Mount Sinai Hospital 17

GNS Healthcare Enters Into Agreement With Dana-Farber Cancer Institute and Mount Sinai School of Medicine 18

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 20

Licensing Agreements 21

Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 21

Mount Sinai Hospital-Key Competitors 22

Mount Sinai Hospital-Key Employees 23

Mount Sinai Hospital-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Joint Venture 24

Recent Developments 25

Government and Public Interest 25

Aug 24, 2018: Mount Sinai researchers discover epigenetic reason for drug resistance in a deadly Melanoma 25

Apr 11, 2018: Simultaneous Chemotherapy and Immunotherapy May Be Better for Some Metastatic Bladder Cancer Patients 26

Other Significant Developments 27

Aug 13, 2018: Artificial Intelligence platform screens for acute neurological illnesses at Mount Sinai 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mount Sinai Hospital, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Key Facts 2

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mount Sinai Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mount Sinai Hospital, Deals By Therapy Area, 2012 to YTD 2018 8

Mount Sinai Hospital, Medical Devices Deals, 2012 to YTD 2018 9

Mount Sinai Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kamada Enters into Agreement with Mount Sinai Acute GvHD International Consortium 11

DBV Technologies Enters Into Research Agreement With Icahn School of Medicine at Mount Sinai For Viaskin 13

National Jewish Health Forms Joint Venture With Icahn School of Medicine at Mount Sinai 15

Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 16

DBV Technologies Enters Into Research Agreement With Mount Sinai Hospital 17

GNS Healthcare Enters Into Agreement With Dana-Farber Cancer Institute and Mount Sinai School of Medicine 18

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 20

Auven Therapeutics Enters Into Licensing Agreement With Icahn School Of Medicine At Mount Sinai For Kiacta 21

Mount Sinai Hospital, Key Competitors 22

Mount Sinai Hospital, Key Employees 23

Mount Sinai Hospital, Other Locations 24

Mount Sinai Hospital, Joint Venture 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Mount Sinai Hospital, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person